Cardiovascular Drugs Market
Cardiovascular Drugs Market Research Report By Drug Class (Antiarrhythmics, Antianginals, Antihypertensives, Lipid-lowering agents, Anticoagulants, Antiplatelet agents, Cardiac glycosides), By Route of Administration (Oral, Intravenous, Subcutaneous, Transdermal, Inhalation), By Indication (Coronary artery disease, Heart failure, Stroke, Atrial fibrillation, Hypertension, Hyperlipidemia, Venous thromboembolism), By Mechanism of Action (Beta-blockers, Calcium channel blockers, ACE inhibitors, Angiotensin II receptor blockers, Diuretics, Statins, Fibrates), By Dosage Form (Tablets, Capsules, Injections, Patches, Implants) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2032
Global Cardiovascular Drugs Market Overview
As per MRFR analysis, the Cardiovascular Drugs Market Size was estimated at 202.34 (USD Billion) in 2022.
The Cardiovascular Drugs Industry is expected to grow from 210.82 (USD Billion) in 2023 to 305.1..